New England Journal of Medicine

Papers
(The H4-Index of New England Journal of Medicine is 291. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine11185
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine7643
Dexamethasone in Hospitalized Patients with Covid-196677
Remdesivir for the Treatment of Covid-19 — Final Report5272
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-194175
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma3743
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-193552
Mental Health and the Covid-19 Pandemic2950
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure2775
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2566
Dapagliflozin in Patients with Chronic Kidney Disease2556
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant2243
Empagliflozin in Heart Failure with a Preserved Ejection Fraction2179
Fair Allocation of Scarce Medical Resources in the Time of Covid-192107
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting2102
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2033
Neurologic Features in Severe SARS-CoV-2 Infection1951
Cytokine Storm1920
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-191918
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents1868
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series1862
Compassionate Use of Remdesivir for Patients with Severe Covid-191838
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility1716
Clinical Characteristics of Covid-19 in New York City1683
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination1683
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results1681
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant1654
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young1592
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer1534
Multiorgan and Renal Tropism of SARS-CoV-21445
Once-Weekly Semaglutide in Adults with Overweight or Obesity1432
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-191408
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia1408
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months1382
Genomewide Association Study of Severe Covid-19 with Respiratory Failure1375
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-191360
Hospitalization and Mortality among Black Patients and White Patients with Covid-191355
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race1317
Olaparib for Metastatic Castration-Resistant Prostate Cancer1295
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-191274
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-191252
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients1224
Lecanemab in Early Alzheimer’s Disease1223
Monkeypox Virus Infection in Humans across 16 Countries — April–June 20221219
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-191208
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma1169
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes1147
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults1143
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers1118
Developing Covid-19 Vaccines at Pandemic Speed1114
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination1098
Severe Covid-191088
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure1085
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation1082
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer1079
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-191053
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host1039
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months1034
Remdesivir for 5 or 10 Days in Patients with Severe Covid-191028
Efficacy of Tocilizumab in Patients Hospitalized with Covid-191027
Multisystem Inflammatory Syndrome in Children in New York State1022
Mild or Moderate Covid-191013
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington1007
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant1005
Colchicine in Patients with Chronic Coronary Disease998
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors997
Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer995
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19970
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma965
Spread of SARS-CoV-2 in the Icelandic Population964
Guillain–Barré Syndrome Associated with SARS-CoV-2962
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma957
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia953
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms952
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia948
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC946
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine935
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes917
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer914
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine912
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction908
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates893
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer888
The Effect of Advances in Lung-Cancer Treatment on Population Mortality883
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19883
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel873
Tirzepatide Once Weekly for the Treatment of Obesity872
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19856
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19854
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis854
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19851
Sotorasib for Lung Cancers with KRAS p.G12C Mutation847
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19840
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer839
How Structural Racism Works — Racist Policies as a Root Cause of U.S. Racial Health Inequities835
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis826
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants816
Waning Immunity after the BNT162b2 Vaccine in Israel803
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab798
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma797
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients791
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma790
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer778
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy776
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2774
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19770
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction766
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery766
Humoral Immune Response to SARS-CoV-2 in Iceland757
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination754
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers747
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine746
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19729
HPV Vaccination and the Risk of Invasive Cervical Cancer719
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting717
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients715
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes700
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents699
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia696
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer689
Covid-19 and Health Care’s Digital Revolution686
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults684
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19676
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis670
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease664
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia662
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile660
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications654
Neuropathological Features of Covid-19653
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons651
Trial of Psilocybin versus Escitalopram for Depression648
Donanemab in Early Alzheimer’s Disease642
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar638
Empagliflozin in Patients with Chronic Kidney Disease638
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19634
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine628
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination624
Autophagy in Human Diseases618
Covid-19 and Kidney Transplantation615
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer612
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer612
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment611
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes610
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma607
Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line606
Vaccine Breakthrough Infections with SARS-CoV-2 Variants606
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease586
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19585
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer577
New-Onset Diabetes in Covid-19572
Rivaroxaban in Peripheral Artery Disease after Revascularization571
ST-Segment Elevation in Patients with Covid-19 — A Case Series571
Racial Health Disparities and Covid-19 — Caution and Context554
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications550
Pathophysiology of Inflammatory Bowel Diseases548
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke538
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa536
The Untold Toll — The Pandemic’s Effects on Patients without Covid-19535
Capmatinib inMETExon 14–Mutated orMET-Amplified Non–Small-Cell Lung Cancer530
Racial Bias in Pulse Oximetry Measurement526
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine526
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest522
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction521
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women520
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19518
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis517
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant514
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing509
Neutralizing Activity of BNT162b2-Elicited Serum500
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy499
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines497
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer494
Children with Covid-19 in Pediatric Emergency Departments in Italy492
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma492
Acquired Resistance to KRASG12C Inhibition in Cancer491
The Toughest Triage — Allocating Ventilators in a Pandemic488
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer487
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations484
Covid-19 — Implications for the Health Care System476
Avacopan for the Treatment of ANCA-Associated Vasculitis471
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer468
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19466
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection462
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma460
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine458
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer458
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization457
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19452
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients451
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers444
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel438
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma437
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer437
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease433
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease431
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5430
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma430
Evidence of Artemisinin-Resistant Malaria in Africa424
Transmission of SARS-CoV-2 in Domestic Cats419
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis418
Evinacumab for Homozygous Familial Hypercholesterolemia417
A Population-Based Study of Genes Previously Implicated in Breast Cancer415
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China411
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19411
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age409
A Bivalent Omicron-Containing Booster Vaccine against Covid-19408
Homologous and Heterologous Covid-19 Booster Vaccinations406
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation405
Microvascular Injury in the Brains of Patients with Covid-19405
Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer404
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine403
Diffuse Large B-Cell Lymphoma400
Structural Racism, Social Risk Factors, and Covid-19 — A Dangerous Convergence for Black Americans397
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer396
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma396
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase395
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma394
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19388
Spectrum of Fibrotic Lung Diseases386
Barrier Enclosure during Endotracheal Intubation385
Migraine384
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia381
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections380
Race and Genetic Ancestry in Medicine — A Time for Reckoning with Racism378
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines377
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure373
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer372
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons370
Osteoarthritis of the Knee366
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants365
Ofatumumab versus Teriflunomide in Multiple Sclerosis363
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women362
Endometrial Cancer361
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria361
Acute-on-Chronic Liver Failure358
Collateral Effect of Covid-19 on Stroke Evaluation in the United States357
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants356
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection355
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS355
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer354
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes353
Endovascular Therapy for Acute Stroke with a Large Ischemic Region349
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings348
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection347
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer345
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19344
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report344
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer339
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.339
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3338
0.033354997634888